Idiopathic interstitial pneumonia following stem cell transplantation

Clinical Transplantation

Volumn 17, Issue 4, 2003, Pages 338-346

  Yamaguchi, Nobuko ^a   Takatsuka, Hiroyuki ^a   Wakae, Takeshi ^a   Okada, Masaya ^a   Fujimoro, Yoshihiro ^a   Okamoto, Takahiro ^a   Kakishita, Eizo ^a   Hara, Hiroshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Angiitis syndrome; Helicobacter pylori; Idiopathic interstitial pneumonia; Inflammatory cytokines; Stem cell transplantation

Indexed keywords

BACTERIUM ANTIBODY; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; CYTOMEGALOVIRUS ANTIBODY; DEXAMETHASONE; GANCICLOVIR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TACROLIMUS; THROMBOMODULIN;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE PREDISPOSITION; FEMALE; GRAFT VERSUS HOST REACTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN HERPESVIRUS 6; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; VASCULITIS; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADULT; ANTIGENS; ANTIGENS, NEOPLASM; CHEMOKINES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG DISEASES, INTERSTITIAL; MALE; MUCINS; RISK FACTORS; SYNDROME; TRANSPLANTATION CONDITIONING; VASCULITIS; WHOLE-BODY IRRADIATION;

EID: 0041620484     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00053.x     Document Type: Article

References (20)

1. Martin PJ, Hansen JA, Storb R, Thomas ED. Human marrow transplantation: an immunological perspective. Adv Immunol 1987: 40: 379.
2. Taynor AE, Schroeder J, Rosa RM et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000: 356: 701.
3. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Eng J Med 2000: 343: 750.
4. Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975: 8: 1.
5. Katzenstein A-LA. Idiopathic interstitial pneumonia. classification and diagnosis. In: Churg A, Katzenstein A-LA eds. The Lung Current Concept. Baltimore: Williams & Wilkins, 1993: 1.
6. Katzenstein A-LA. Idiopathic interstitial pneumonia. In: Katzenstein A-LA ed. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. New York: W.B. Saunders, 1997: 48.
7. Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994: 186: 130.
8. Wada H, Mori A, Okada M et al. Treatment of intestinal graft-versus-host disease using betamethasone enemas. Transplantation 2001: 72: 1451.
9. Kohno N, Yokoyama A, Hirasawa Y et al. Comparative studies of circulating KL-6 type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Respir Med 1997: 91: 558.
10. Ashida T, Higashishiba M, Sumimoto Y et al. KL-6 in patients with pulmonary complications after allogeneic bone marrow transplantation. Int J Hematol 2001: 74: 464.
11. Fauci AS. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978: 89: 660.
12. Phillip MR. Neutrophil adhesion and autoimmune vascularinjury. Clin Asp Autoimmunity 1989: 3: 6.
13. Argenbright LW, Barton RW. Interactions of leukocyte integrins with inter-cellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. J Clin Invest 1992: 89: 259.
14. Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000: 26: 419.
15. Ogawa M. Mechanisms of the development of organ failure following surgical insult: The 'second attack' theory. Clin Intensive Care 1996: 7: 34.
16. Cardozo BL, Zoetelief H, Van Bekkum DW, Zurcher C, Hagenbeek A. Lung damage following bone marrow transplantation: 1. The contribution of irradiation. Int J Radiat Oncol Biol Phys 1985: 11: 907.
17. Alkout AM, Blackwell CC, Weir DM. Increased inflammatory response of person of blood group 0 to Helicobacter pylori. J Infect Dis 2000: 181: 1364.
18. Supajatura V, Ushio H, Wada A et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002: 168: 2603.
19. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Hedlicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996: 110: 1744.
20. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998: 160: 2401.